Insulet | PODD - PE Price to Earnings


Insulet reported 38.83 in PE Price to Earnings for its fiscal quarter ending in March of 2026.





Pe Change Date
Abbott 24.94 5.78 Mar/2026
Align Technology 22.78 3.05 Mar/2026
AtriCure 34.15 2.7 Jun/2022
Avanos Medical 18.02 108.8 Mar/2026
Baxter International 86 68.9 Dec/2025
Becton, Dickinson and Co. 17.68 114.67 Dec/2025
Boston Scientific 32.35 5.17 Mar/2026
Cardinal Health 30.4 5.87 Mar/2026
Cooper Companies 23.27 16.99 Mar/2026
Dexcom 24.73 7.45 Mar/2026
Edwards Lifesciences 26.86 4.76 Mar/2026
Eli Lilly 40.27 0.06 Mar/2026
Globus Medical 35.3 10.24 Mar/2026
ICU Medical 158.3 38.83 Dec/2025
Inogen 69.33 30.67 Sep/2021
Insulet 38.83 16.24 Mar/2026
Integra LifeSciences 5.07 1.52 Mar/2026
J&J 29.43 4.9 Jun/2026
Medtronic 19.66 3.1 Mar/2026
Merit Medical Systems 45.2 6.08 Dec/2025
Roche Holding 16.09 3.51 Dec/2025
Solventum Corp 189.1 183.21 Mar/2026
Stryker 30.44 1.69 Mar/2026
Tandem Diabetes Care 681.05 189.32 Mar/2022
Teleflex 49.25 21.46 Mar/2026
West Pharmaceutical Services 31.99 5.76 Mar/2026
Zimmer Biomet Holdings 25.47 7.56 Mar/2026